-
Mashup Score: 0
Firas Baidoun, MD, Cleveland Clinic, Cleveland, OH, talks on the impact of gender and HPV status on overall survival (OS)…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
Ghassan K. Abou-Alfa, MD, MBA, Memorial Sloan Kettering Cancer Center, New York, NY, discusses the results of a Phase II…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Tiragolumab and atezolizumab in metastatic esophageal cancer - 2 year(s) ago
Zev A. Wainberg, MD, Msc, UCLA School of Medicine, Los Angeles, CA, provides an overview of the Phase Ib trial…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Monitoring MRD by ctDNA in resectable CRC - 2 year(s) ago
Hiromichi Shirasu, MD, Shizuoka Cancer Center, Shizuoka, Japan, discusses findings of a molecular subgroup analysis of the CIRCULATE-Japan study, identifying…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0VALENTINO: VAF as prognostic marker in mCRC - 2 year(s) ago
Paolo Manca, MD, Istituto Nazionale dei Tumori Milano, Milano, Italy discusses the update results from the VALENTINO trial; a Phase…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Adjuvant chemotherapy in gastric adenocarcinoma - 2 year(s) ago
Lei Deng, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY, discusses the prognostic and predictive role of preoperative chemotherapy sensitivity…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 15KEYNOTE-811: trastuzumab + chemotherapy with or without pembrolizumab for HER2+ G/GEJ cancer - 2 year(s) ago
Combination therapy with the anti-HER2 antibody trastuzumab with pembrolizumab and chemotherapy is the current standard of care for patients with…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Averectal: neoadjuvant short-course RT followed by chemo + avelumab in rectal adenocarcinoma - 2 year(s) ago
Post-surgery chemotherapy and chemoradiotherapy confer no survival advantage and have low patient compliance, only ~60-70% of patients will complete the…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
First-line bevacizumab is hypothesized to interfere with second-line activity of the EGFR inhibitor cetuximab during the treatment of colorectal cancer…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Impact of timing of perioperative chemotherapy on OS in patients with CRC liver metastases - 2 year(s) ago
Firas Baidoun, MD, Cleveland Clinic, Cleveland, OH, discusses the findings of a propensity score matching of the National Cancer Database…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Firas Baidoun of @ClevelandClinic talks on impact of gender and HPV status on anal squamous cell carcinoma survival ๐จโโ๏ธ๐ฅ Watch here ๐https://t.co/LXgvrlwtM2๐ @myESMO #WorldGI2021 #GIsm #Oncology